Quoc Le-Nguyen Biography and Net Worth

Insider of 89bio

Quoc Le-Nguyen is the chief technical operations officer and head of quality of 89bio. He has over 25 years of experience in biopharmaceutical operations from large pharma and small startup and has the rare experience of both starting a manufacturing operation and closing a manufacturing plant. Quoc is a seasoned executive with extensive knowledge in technical operations and product supply, including building out facilities, organization, and systems as well as advancing programs through various stages of clinical development to licensure. His most recent position was SVP, global head of technical operations & quality for Aduro BioTech, where he was responsible for clinical supply including analytical/process development, manufacturing, supply chain, and quality for all three platforms: Cell Therapy, Small Molecule, and Antibody. Prior to that, Quoc was the VP of manufacturing operations for Bayer Healthcare, responsible for the Betaferon/Betaseron franchise. Quoc also played a critical role in the startup of BioMarin, in the development and approval of their first product, Adurazyme, in 2001.

Quoc holds a BS in biochemistry from the University of California at Davis.

What is Quoc Le-Nguyen's net worth?: The estimated net worth of Quoc Le-Nguyen is at least $1.98 million as of January 15th, 2025. Le-Nguyen owns 271,833 shares of 89bio stock worth more than $1,976,226 as of April 1st. This net worth approximation does not reflect any other assets that Le-Nguyen may own. Additionally, Le-Nguyen receives a salary of $702,870.00 as Insider at 89bio. Learn More about Quoc Le-Nguyen's net worth.
How old is Quoc Le-Nguyen?: Le-Nguyen is currently 56 years old. There are 4 older executives and no younger executives at 89bio. The oldest executive at 89bio is Dr. Harry Mansbach M.D., Chief Medical Officer, who is 59 years old. Learn More on Quoc Le-Nguyen's age.
What is Quoc Le-Nguyen's salary?: As the Insider of 89bio, Inc., Le-Nguyen earns $702,870.00 per year. There are 2 executives that earn more than Le-Nguyen. The highest earning executive at 89bio is Mr. Rohan Palekar, CEO & Director, who commands a salary of $1,060,000.00 per year. Learn More on Quoc Le-Nguyen's salary.
How do I contact Quoc Le-Nguyen?: The corporate mailing address for Le-Nguyen and other 89bio executives is 142 SANSOME STREET SECOND FLOOR, SAN FRANCISCO CA, 94104. 89bio can also be reached via phone at 415-432-9270 and via email at investors@89bio.com. Learn More on Quoc Le-Nguyen's contact information.
Has Quoc Le-Nguyen been buying or selling shares of 89bio?: Quoc Le-Nguyen has not been actively trading shares of 89bio during the past quarter. Most recently, Quoc Le-Nguyen sold 10,963 shares of the business's stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $6.49, for a transaction totalling $71,149.87. Following the completion of the sale, the insider now directly owns 271,833 shares of the company's stock, valued at $1,764,196.17. Learn More on Quoc Le-Nguyen's trading history.
Who are 89bio's active insiders?: 89bio's insider roster includes Gregory Grunberg (Director), Michael Hayden (Director), Morrow III (Director), Kathleen Laporte (Director), Quoc Le-Nguyen (Insider), Ryan Martins (CFO), Charles Mcwherter (Director), Rohan Palekar (CEO), Ollin Sykes (Director), and Ram Waisbourd (Insider). Learn More on 89bio's active insiders.
Are insiders buying or selling shares of 89bio?: In the last twelve months, 89bio insiders bought shares 5 times. They purchased a total of 5,744,285 shares worth more than $50,235,693.75. In the last twelve months, insiders at the sold shares 1 times. They sold a total of 10,963 shares worth more than $71,149.87. The most recent insider tranaction occured on January, 30th when Director Ra Capital Management, L.P. bought 5,714,285 shares worth more than $49,999,993.75. Insiders at 89bio own 2.8% of the company. Learn More about insider trades at 89bio.
Information on this page was last updated on 1/30/2025.

Quoc Le-Nguyen Insider Trading History at 89bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/15/2025	Sell	10,963	$6.49	$71,149.87	271,833
5/9/2023	Sell	13,683	$18.11	$247,799.13	164,971

Quoc Le-Nguyen Buying and Selling Activity at 89bio

89bio Company Overview

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. The company was incorporated in 2018 and is headquartered in San Francisco, California.

Today's Range

Now: $6.80

$6.70

$7.24

50 Day Range

MA: $9.18

$6.58

$11.66

2 Week Range

Now: $6.80

$5.99

$11.84

Volume

2,079,568 shs

Average Volume

1,238,886 shs

Market Capitalization

$992.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.17

Quoc Le-Nguyen Biography and Net Worth

What is Quoc Le-Nguyen's net worth?

How old is Quoc Le-Nguyen?

What is Quoc Le-Nguyen's salary?

How do I contact Quoc Le-Nguyen?

Has Quoc Le-Nguyen been buying or selling shares of 89bio?

Who are 89bio's active insiders?

Are insiders buying or selling shares of 89bio?